關(guān)于STAAR Surgical

40多年來(lái)，STAAR Surgical公司一直專注于眼科醫(yī)療產(chǎn)品的設(shè)計(jì)、研發(fā)和制造。EVO ICL為患者提供視覺(jué)自由，減少或消除患者對(duì)眼鏡或隱形眼鏡的依賴。所有的 ICL晶體都具有可折疊性，這使得ICL醫(yī)生可以通過(guò)一個(gè)微小的切口，將晶體植入，無(wú)需切削角膜。STAAR Surgical公司將這樣的晶體稱為Implantable Collamer Lens 或ICL，其中包括新一代產(chǎn)品EVO ICL。迄今為止，ICL晶體植入量已突破300萬(wàn)枚，遍及全球75個(gè)國(guó)家和地區(qū)。

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer Lens or ICL,which includes the EVO Visian ICL product line. More than 3,000,000 Visian ICLs have been sold to date and STAAR markets these lenses in over 75 countries.